ABSTRACT Introduction: Inflammatory bowel diseases (IBDs) are lifelong conditions
causing relapsing inflammation of the intestine. In the absence of a cure, clinical …

Inflammatory bowel disease (IBD) is a chronic disease of unknown etiology which mostly
involves the intestine and requires a personalized approach for treatment. IBD represents a …

Personalized care in inflammatory bowel diseases (IBD) hinges on parsing the
heterogeneity of IBD patients through prognostication of their disease course and …

The “big data” in inflammatory bowel disease opens a route of detection of predictors that
can determine the prognosis of each patient and allow the individualized selection of more …

Inflammatory bowel diseases [IBD] such as Crohn's disease [CD] and ulcerative colitis [UC]
are complex conditions presenting with a wide range of phenotypes. Given major variation …

Inflammatory bowel diseases (IBD) are chronic conditions that primarily affect the
gastrointestinal tract, with a complex pathogenesis; they are characterized by a significant …

The pathogenesis of inflammatory bowel disease (IBD) is complex and multifactorial.
Undertreated disease has substantial individual and societal consequences. Current patient …

Despite recent advances in the understanding of the pathogenesis of inflammatory bowel
diseases (IBD) and advent of multiple targeted therapies, approximately one-third of patients …

Inflammatory bowel disease (IBD) is a heterogeneous disorder in terms of age at onset,
clinical phenotypes, severity, disease course, and response to therapy. This underlines the …

There is great heterogeneity among inflammatory bowel disease (IBD) patients in terms of
pathogenesis, clinical manifestation, response to treatment, and prognosis, which requires …